Qube Research & Technologies Ltd - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,599,402
-51.0%
126,862
-52.5%
0.01%
-63.2%
Q2 2023$5,302,429
+213.8%
266,856
+170.5%
0.02%
+171.4%
Q1 2023$1,689,857
+123.5%
98,649
+79.6%
0.01%
+16.7%
Q2 2022$756,000
+52.1%
54,935
+75.3%
0.01%
+50.0%
Q1 2022$497,000
-19.6%
31,345
+10.7%
0.00%
-20.0%
Q4 2021$618,000
+2.0%
28,316
+107.4%
0.01%
-50.0%
Q1 2021$606,000
+146.3%
13,650
+26.1%
0.01%
+25.0%
Q4 2019$246,00010,8260.01%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,812,491$234,534,00010.10%
TANG CAPITAL MANAGEMENT LLC 2,965,485$41,369,0005.81%
Ghost Tree Capital, LLC 650,000$9,068,0002.40%
Boxer Capital, LLC 1,466,051$20,451,0001.39%
Vivo Capital, LLC 860,648$12,006,0001.09%
Samsara BioCapital, LLC 128,197$1,788,0001.03%
Cormorant Asset Management, LP 1,568,550$21,881,0001.02%
Perceptive Advisors 2,189,010$30,537,0000.80%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,677,367$23,399,0000.74%
Eventide Asset Management 1,415,000$19,739,0000.64%
View complete list of ROCKET PHARMACEUTICALS INC shareholders